Evidence map›Paper›PMID 18230652›Full record

ArticleJournal of cell science2008

Integrin alpha9 beta1 is a receptor for nerve growth factor and other neurotrophins.

Izabela Staniszewska, Ilker K Sariyer, Shimon Lecht, Meghan C Brown, Erin M Walsh, George P Tuszynski, Mahmut Safak, Philip Lazarovici, Cezary Marcinkiewicz

Open access · greenAbstract read
In one paragraph

Article in Journal of cell science, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Review
  3. BDNF and its signaling in cancer.Journal of cancer research and clinical oncology · 2023
    Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Visualization of integrin molecules by fluorescence imaging and techniques.Biocell : official journal of the Sociedades Latinoamericanas de Microscopia Electronica ... et. al · 2021
    Article
  10. Article
  11. Review
  12. Review
  13. Role of the Nervous System in Tumor Angiogenesis.Cancer microenvironment : official journal of the International Cancer Microenvironment Society · 2018
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Expression of an Activated Integrin Promotes Long-Distance Sensory Axon Regeneration in the Spinal Cord.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2016
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Izabela StaniszewskaDepartment of Neuroscience, Center for Neurovirology and Cancer Biology, Temple University, School of Medicine, Philadelphia, PA 19122, USA.
Ilker K Sariyer
Shimon Lecht
Meghan C Brown
Erin M Walsh
George P Tuszynski
Mahmut Safak
Philip Lazarovici
Cezary Marcinkiewicz
Temple University · USHebrew University of Jerusalem · IL

Funding

Role of Agno Protein in JC Virus Life CycleR01NS043108 · NINDS · TEMPLE UNIV OF THE COMMONWEALTH · PI SAFAK, MAHMUT · 2002 to 2012
$3.3M
Targeting alfa 1beta1 integrin in cancer developmentR01CA100145 · NCI · TEMPLE UNIV OF THE COMMONWEALTH · PI MARCINKIEWICZ, CEZARY · 2004 to 2007
$934k
NCI NIH HHS CA 100145NCI NIH HHS R01 CA100145NINDS NIH HHS NS 43108-05NINDS NIH HHS R01 NS043108
6 · The paper itself

Abstract

The integrin alpha9beta1 is a multifunctional receptor that interacts with a variety of ligands including vascular cell adhesion molecule 1, tenascin C and osteopontin. We found that this integrin is a receptor for nerve growth factor (NGF) and two other neurotrophins, brain-derived neurotrophic factor and NT3, using a cell adhesion assay with the alpha9SW480 cell line. Interaction of alpha9beta1 with NGF was confirmed in an ELISA assay by direct binding to purified integrin. alpha9beta1 integrin binds to neurotrophins in a manner similar to another common neurotrophin receptor, p75(NTR) (NGFR), although alpha9beta1 activity is correlated with induction of pro-survival and pro-proliferative signaling cascades. This property of alpha9beta1 resembles the interaction of NGF with a high affinity receptor, TrkA, however, this integrin shows a low affinity for NGF. NGF induces chemotaxis of cells expressing alpha9beta1 and their proliferation. Moreover, alpha9beta1 integrin is a signaling receptor for NGF, which activates the MAPK (Erk1/2) pathway. The alpha9beta1-dependent chemotactic ability of NGF appears to result from the activation of paxillin.

Indexed as

AnimalsCell AdhesionCell Line, TumorCell MovementCell ProliferationEnzyme-Linked Immunosorbent AssayHumansIntegrinsNerve Growth FactorNerve Growth FactorsProtein BindingRatsReceptor, Nerve Growth FactorReceptor, trkAReverse Transcriptase Polymerase Chain Reactionintegrin alpha 9 beta 1IntegrinsNerve Growth FactorNerve Growth FactorsReceptor, Nerve Growth FactorReceptor, trkA

Identifiers

PMID18230652
PMCPMC2744358
OpenAlexW2057950902

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.